Beam Therapeutics Inc. logo BEAM - Beam Therapeutics Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 8
SELL 1
STRONG
SELL
0
| PRICE TARGET: $48.00 DETAILS
HIGH: $80.00
LOW: $26.00
MEDIAN: $40.00
CONSENSUS: $48.00
UPSIDE: 67.60%

Profitability Ratios

Ratio Value
GP Margin 84.0%
EBIT Margin -25.9%
EBITDA Margin -21.4%
Operating Margin -274.6%
Pretax Margin -57.2%
Cont. Ops Margin -57.2%
Net Margin -57.2%
Bottom Line Margin -57.2%

Liquidity Ratios

Ratio Value
Current Ratio 13.09
Quick Ratio 13.09
Solvency Ratio -0.303
Cash Ratio 3.04

Valuation Ratios

Ratio Value
Price/Earnings
-34.27
Peers avg: 25.1
PEG Ratio 0.42
Forward PEG 0.42
Price/Book 2.21
Price/Sales 19.62
Price/FCF -7.61
Price/Op Cash Flow -7.94

Debt Ratios

Ratio Value
Debt/Assets 0.1984
Debt/Equity 0.2373
Debt/Capital 0.1918
Long-Term Debt/Capital 0.1014
Financial Leverage 1.20

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.15
Operating Cash Flow Ratio -3.560
Operating Cash Flow/Sales -247.0%
Free Cash Flow/Operating Cash Flow 104.3%

Coverage Ratios

Ratio Value
Debt Service Coverage -0.52
Interest Coverage -8.7735
Short-Term Operating Cash Flow Coverage -24.03
Operating Cash Flow Coverage -1.17
Capital Expenditure Coverage -23.09
Dividend + Capital Expenditure Coverage -23.09

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 1.41
EPS -0.809
Debt/Share 3.4135
Cash/Share 12.59
Book Value/Share 12.52
Tangible BV/Share 12.52
Equity/Share 12.52
Operating Cash Flow/Share -3.489
Capital Expenditure/Share 0.151
FCF/Share -3.640

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.000
Earnings Before Tax/EBIT 0.208
Price/Fair Value 2.21
Debt/Market Cap 0.0562
Effective Tax Rate 0.0%
Enterprise Value Multiple -91.59